Literature DB >> 22247023

Finding ovarian cancer.

Patricia Hartge, James L Speyer.   

Abstract

Entities:  

Mesh:

Year:  2012        PMID: 22247023      PMCID: PMC3260133          DOI: 10.1093/jnci/djr518

Source DB:  PubMed          Journal:  J Natl Cancer Inst        ISSN: 0027-8874            Impact factor:   13.506


× No keyword cloud information.
  8 in total

1.  Breast cancer tumor size, nodal status, and prognosis: biology trumps anatomy.

Authors:  Elizabeth A Comen; Larry Norton; Joan Massagué
Journal:  J Clin Oncol       Date:  2011-05-23       Impact factor: 44.544

2.  Potential role of HE4 in multimodal screening for epithelial ovarian cancer.

Authors:  Nicole Urban; Jason D Thorpe; Lindsay A Bergan; Robin M Forrest; Archana V Kampani; Nathalie Scholler; Kathy C O'Briant; Garnet L Anderson; Daniel W Cramer; Christine D Berg; Martin W McIntosh; Patricia Hartge; Charles W Drescher
Journal:  J Natl Cancer Inst       Date:  2011-09-14       Impact factor: 13.506

3.  Effect of very small tumor size on cancer-specific mortality in node-positive breast cancer.

Authors:  Jennifer Y Wo; Kun Chen; Bridget A Neville; Nancy U Lin; Rinaa S Punglia
Journal:  J Clin Oncol       Date:  2011-05-23       Impact factor: 44.544

4.  Nodal status and clinical outcomes in a large cohort of patients with triple-negative breast cancer.

Authors:  Leonel F Hernandez-Aya; Mariana Chavez-Macgregor; Xiudong Lei; Funda Meric-Bernstam; Thomas A Buchholz; Limin Hsu; Aysegul A Sahin; Kim-Anh Do; Vicente Valero; Gabriel N Hortobagyi; Ana Maria Gonzalez-Angulo
Journal:  J Clin Oncol       Date:  2011-05-23       Impact factor: 44.544

5.  Ovarian cancer biomarker performance in prostate, lung, colorectal, and ovarian cancer screening trial specimens.

Authors:  Daniel W Cramer; Robert C Bast; Christine D Berg; Eleftherios P Diamandis; Andrew K Godwin; Patricia Hartge; Anna E Lokshin; Karen H Lu; Martin W McIntosh; Gil Mor; Christos Patriotis; Paul F Pinsky; Mark D Thornquist; Nathalie Scholler; Steven J Skates; Patrick M Sluss; Sudhir Srivastava; David C Ward; Zhen Zhang; Claire S Zhu; Nicole Urban
Journal:  Cancer Prev Res (Phila)       Date:  2011-03

6.  Effect of screening on ovarian cancer mortality: the Prostate, Lung, Colorectal and Ovarian (PLCO) Cancer Screening Randomized Controlled Trial.

Authors:  Saundra S Buys; Edward Partridge; Amanda Black; Christine C Johnson; Lois Lamerato; Claudine Isaacs; Douglas J Reding; Robert T Greenlee; Lance A Yokochi; Bruce Kessel; E David Crawford; Timothy R Church; Gerald L Andriole; Joel L Weissfeld; Mona N Fouad; David Chia; Barbara O'Brien; Lawrence R Ragard; Jonathan D Clapp; Joshua M Rathmell; Thomas L Riley; Patricia Hartge; Paul F Pinsky; Claire S Zhu; Grant Izmirlian; Barnett S Kramer; Anthony B Miller; Jian-Lun Xu; Philip C Prorok; John K Gohagan; Christine D Berg
Journal:  JAMA       Date:  2011-06-08       Impact factor: 157.335

7.  Assessing lead time of selected ovarian cancer biomarkers: a nested case-control study.

Authors:  Garnet L Anderson; Martin McIntosh; Lieling Wu; Matt Barnett; Gary Goodman; Jason D Thorpe; Lindsay Bergan; Mark D Thornquist; Nathalie Scholler; Nam Kim; Kathy O'Briant; Charles Drescher; Nicole Urban
Journal:  J Natl Cancer Inst       Date:  2009-12-30       Impact factor: 13.506

8.  Predictive value of symptoms for ovarian cancer: comparison of symptoms reported by questionnaire, interview, and general practitioner notes.

Authors:  Anita W W Lim; David Mesher; Aleksandra Gentry-Maharaj; Nyaladzi Balogun; Ian Jacobs; Usha Menon; Peter Sasieni
Journal:  J Natl Cancer Inst       Date:  2012-01-13       Impact factor: 13.506

  8 in total
  1 in total

Review 1.  From differences in means between cases and controls to risk stratification: a business plan for biomarker development.

Authors:  Nicolas Wentzensen; Sholom Wacholder
Journal:  Cancer Discov       Date:  2013-01-08       Impact factor: 39.397

  1 in total

北京卡尤迪生物科技股份有限公司 © 2022-2023.